CAS: 161975-39-9; Tert-Butyl 4-(((Methylsulfonyl)Oxy)Methyl)Piperidine-1-Carboxylate

该化合物是一种化学化合物,其特征是管状环,这是六人组成的饱和氮-含氮-乙基环."Boc"(乙基-丁基氧碳基)组是一个保护氨的团体,可增强化合物在各种化学反应中的稳定性和反应性.甲烷硫基甲基组的存在表明,该化合物有一个甲烷硫基-氟基甲基功能组,可以作为核分裂替代反应中的分离组.该化合物通常用于有机合成,特别是用于制造更复杂的分子,因为其具有各种变异的能力.其结构表明,该化合物在医药化学中的潜在应用,特别是在制药业的开发中.该化合物的溶解性,再活性和稳定性可以受到与管环相连的功能组的影响,使其在合成过程中成为多功能的中间体.应当与所有化学物质一样,在与其反应和毒性相关的潜在危害下,遵守安全和处理预防措施.

结构式图片

相似化合物

147699-19-2 162166-99-6 159275-16-8

欧盟法规

REACH注册C&L通报

上下游产品

CAS号124-63-0 甲基磺酰氯 | CAS号123855-51-6 N-B°C-4-哌啶甲醇 | CAS号7143-01-3 甲基磺酸酐 | CAS号24424-99-5 二碳酸二叔丁酯 | CAS号6457-49-4 4-哌啶甲醇 | CAS号84358-13-4 1-B°C-4-哌啶甲酸 | CAS号498-94-2 4-哌啶甲酸 | CAS号145508-94-7 1-叔丁氧羰基-4-碘甲基哌啶 | CAS号144222-22-0 1-B°C-4-(氨基甲基)哌啶 | CAS号256411-39-9 1-B°C-4-(氰基甲基)哌啶 | CAS号176967-62-7 4-(Piperidin-4-... | CAS号917903-78-7 3-(4-哌啶基甲氧基)苯甲酸甲酯

合成工艺路线路线简述

  • 合成目标产物 1-Boc-4-Methanesulfonyloxymethyl-Piperidine 主要起始原料 Methanesulfonyl Chloride And N-Boc-4-Piperidinemethanol
  • (文献来源)合成步骤主要原料 Methanesulfonyl Chloride 和 N-Boc-4-Piperidinemethanol
N-Boc-4-哌啶甲酸乙酯置于lithium Aluminium Tetrahydride,三乙胺体系中,用 四氢呋喃,二氯甲烷 用作溶剂,化学反应 16.0H,反应生成1-Boc-4-甲磺酰基氧甲基哌啶
参考文献:Polyfluorinated Compounds Acting As Bruton Tyrosine Kinase Inhibitors
标题:Polyfluorinated Compounds Acting As Bruton Tyrosine Kinase Inhibitors
摘要:本文描述了一种新型的多氟取代吡唑嘧啶化合物或其盐.这些化合物是布鲁顿酪氨酸激酶(btk)抑制剂.这些化合物可能具有更好的btk抑制选择性和药代动力学特性.本文披露了这些化合物的合成方法.本文还披露了多氟取代苯甲酮和取代苯氧基苯的新型合成方法.还披露了包括上述btk抑制剂的药物组合物.本发明还涉及包含上述化合物作为活性成分的药物配方.本发明还包括通过给予btk抑制剂及其配方来治疗和抑制自身免疫疾病,过敏性疾病,炎症性疾病和癌症的治疗方法.

海关参考信息

专利信息


专利号:EP-3091007-A1
优先权日:2015-05-08
标 题 :Process for the preparation of piperidine compounds
发明人:ATTOLINO EMANUELE; RIZZO ELISABETH; ROSSI DAVIDE
权利人:DIPHARMA FRANCIS SRL
摘要:The present invention relates to a process for the preparation of intermediates useful in the synthesis of efinaconazole and their use in the synthesis of efinaconazole.

专利号:US-2023192718-A1
优先权日:2018-03-30
标 题 :Bicyclic enone carboxylates as modulators of transporters and uses thereof
发明人:SANDANAYAKA VINCENT
权利人:NIROGY THERAPEUTICS INC
摘要:The invention generally relates to the field of monocarboxylate transporter inhibitors, and more particularly to new bicyclic enone carboxylate enone compounds, the synthesis and use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with monocarboxylate transporter activity such as in treating cancer and other neoplastic disorders, tissue and organ transplant rejection.

专利号:US-7645754-B2
优先权日:2001-12-20
标题 :Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use
发明人:CASTELHANO ARLINDO; MCKIBBEN BRYAN; STEINIG ARNO
权利人:OSI PHARM INC
摘要:The subject invention provides compounds having the structure: n n n n n n n n n n n n wherein,n R 1 is a substituted or unsubstituted alkyl, wherein the substituent is hydroxyl, dihydroxy, carboxyl, —C(â•?O)NR a R b , —NR a R b , —NR a C(â•?O)NR a R b , —NR a C(â•?O)OR a , —OC(â•?O)NR a R b , or —NHC(â•?O) R a ; R 2 is hydrogen or a substituted or unsubstituted alkyl, wherein the substituent is hydroxyl, dihydroxy, carboxyl, —C(â•?O)NR a R b , —NR a R b , —NR a C(â•?O)NR a R b , —NR a C(â•?O)OR a , —OC(â•?O)NR a R b , or —NHC(â•?O)R a , or R 1 , R 2 and N together form a substituted piperazine, substituted azetidine ring, or a pyrrolidine ring substituted with —(CH 2 ) 2 OH or —CH 2 C(â•?O)OH; R 3 is a substituted or unsubstituted phenyl or a 5-6 membered heteroaryl ring, wherein the substituent is halogen, hydroxyl, cyano, (C 1 -C 15 )alkyl, (C 1 -C 15 )alkoxy, or —NR a R b ; R 4 is hydrogen or substituted or unsubstituted (C 1 -C 15 )alkyl; R 5 is —(CH 2 ) m OR 6 , —CHNOR 7 , —C(â•?O)NR 8 R 9 , —(CH 2 ) m C(â•?O)OR 10 , —(CH 2 ) k C(â•?O)NR 11 R 12 ;n wherein R 6 is a substituted or unsubstituted (C 1 -C 30 )alkyl, (C 3 -C 10 )cycloalkyl, or an aryl, heteroaryl or 4-8 membered heterocyclic ring; R 7 is hydrogen, or a substituted or unsubstituted (C 1 -C 30 )alkyl, (C 1 -C 30 )alkylaryl; R 8 and R 9 are each independently hydrogen, or a substituted or unsubstituted (C 1 -C 30 )alkyl, (C 1 -C 30 )alkylaryl, (C 1 -C 30 )alkylamino, (C 1 -C 30 )alkoxy, or a saturated or unsaturated, monocyclic or bicyclic, carbocyclic or heterocyclic ring, or R 8 , N, and R 9 together form a substituted or unsubstituted 4-8 membered heterocyclic ring; R 10 is hydrogen or a substituted or unsubstituted (C 1 -C 30 )alkyl, (C 3 -C 10 )cycloalkyl, or an aryl, heteroaryl or heterocyclic ring; R 11 , N and R 12 together form a 4-8 membered heterocyclic ring; R a and R b are each independently hydrogen or alkyl; m is 0, 1, 2 or 3; and k is 1, 2 or 3,n nor a specific enantiomer thereof, or a specific tautomer thereof, or a pharmaceutically acceptable salt thereof, and a method for treating a disease associated with the A 2b adenosine receptor in a sbject in need of such treatment comprising administering to the subject a therapeutically effective amount of the compounds of the invention.

专利号:US-9861636-B2
优先权日:2014-04-29
标题 :Polyfluorinated compounds acting as bruton tyrosine kinase inhibitors
发明人:HE WEI
权利人:HE WEI; ZHEJIANG DTRM BIOPHARMA CO LTD
摘要:Described herein is a novel series of multi-fluoro-substituted pyrazolopyrimidine compounds or salts thereof. These compounds are Bruton's tyrosine kinase (BTK) inhibitors. These compounds may possess better BTK inhibition selectivity and pharmacokinetic properties. Disclosed herein are the synthesis methods of these compounds. Disclosed herein are novel synthesis methods of the multi-fluoro-substituted benzophenone and substituted phenoxy benzene. Also disclosed are pharmaceutical compositions comprising the BTK inhibitors described herein. The present invention also relates to pharmaceutical formulations comprising the compounds described herein as active ingredients. The present invention also includes the therapeutic methods by administering the BTK inhibitors and their formulations to treat and inhibit autoimmune disease, hypersensitivity disease, inflammatory diseases and cancer.

专利号:US-2010234603-A1
优先权日:2009-03-13
标题:Process for Making Substituted Aryl Sulfone Intermediates
发明人:LINGHU XIN; LINN KATHLEEN; MALONEY KEVIN M; MCLAUGHLIN MARK; QIAN GANG
权利人:LINGHU XIN; LINN KATHLEEN; MALONEY KEVIN M; MCLAUGHLIN MARK; QIAN GANG
摘要:The present invention relates to novel substituted aryl sulfone intermediates and processes for preparing the same. An aspect of this invention relates to a process for making substituted aryl sulfone intermediates utilizing a one-pot deacylation-carbon/sulfur bond formation step. The invention also relates to a process for preparing intermediates that are used to make the compounds of formula I. Some of the advantages of the present invention include manufacturing flexibility and efficiency, high yield synthesis using a one pot deacylation and carbon-sulfur bond formation step of a thioester intermediate and the like. This and other aspects of the invention will be realized upon review of the specification as a whole.

专利号:US-2010234604-A1
优先权日:2009-03-13
标题:Process for Making Substituted Aryl Sulfone Intermediates
发明人:LINGHU XIN; LINN KATHLEEN; MALONEY KEVIN M; MCLAUGHLIN MARK; QIAN GANG
权利人:LINGHU XIN; LINN KATHLEEN; MALONEY KEVIN M; MCLAUGHLIN MARK; QIAN GANG
摘要:The present invention relates to novel substituted aryl sulfone intermediates and processes for preparing the same. An aspect of this invention relates to a process for making substituted aryl sulfone intermediates utilizing a one-pot deacylation-carbon/sulfur bond formation step. The invention also relates to a process for preparing intermediates that are used to make the compounds of formula I. Some of the advantages of the present invention include manufacturing flexibility and efficiency, high yield synthesis using a one pot deacylation and carbon-sulfur bond formation step of a thioester intermediate and the like. This and other aspects of the invention will be realized upon review of the specification as a whole.
杭州凯方科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hzchempro.com
企业联系电话:17758012822👤
📞杭州凯方科技有限公司 ⚠️参考联系方式
联系人:韩津
电话:17758012822
手机:17758012822

邮箱:Sales@hzchempro.com
通信地址: 杭州市祥园路泰嘉园
邮编: 310013
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:杭州市祥园路泰嘉园
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
安徽德信佳生物医药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jndxj.com
企业联系电话:0531-82375892/15562613975👤
📞安徽德信佳生物医药有限公司 ⚠️参考联系方式
联系人:贾女士
电话:0531-82375892/15562613975
手机:15562613975
传真:QQ 2111416786
邮箱:3416953599@qq.com
通信地址: 安徽省阜阳市太和县经济开发区和谐大道9号
邮编: 250100
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:安徽省阜阳市太和县经济开发区和谐大道9号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知